Articles tagged "Kidney transplantation"

2021 American Transplant Congress
Organ Decline Rate and Outcomes of Shared Kidneys from OneLegacy OPO Donation Service Area in Los Angeles
M. Hussain¹, P. Homkalrias¹, K. Wheeler², G. Danovitch¹, S. Bunnapradist¹
¹UCLA David Geffen School of Medicine, Los Angeles, CA, ²OneLegacy, Los Angeles, CA
*Purpose: Background: 20% recovered kidneys are discarded in the US. Southern California has a high number of End-Stage Kidney Disease patients and the waitlist time…
2021 American Transplant Congress
Two-for-One Kidney Transplant Outcomes
C. Malanga¹, H. Madeem², K. Robichaux², J. Buggs³, A. Kumar¹, V. Bowers³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: In the United States, over 91,000 people are on the waiting list for a kidney transplant. Concurrently, 3,500 kidneys deemed to be of marginal…
2021 American Transplant Congress
True Living Donation Experiences: A Thematic Analysis of Storytelling from Kidney Living Donors
E. Ho¹, E. H. Wood², R. Pines³, L. A. Davis⁴, S. M. Advani⁵, A. D. Waterman²
¹Terasaki Institute, Los Angeles, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Cottage Hospital, Santa Barbara, CA, ⁴DeSales University, Center Valley, PA, ⁵National Human Genome Research Institute (NIH), Bethesda, MD
*Purpose: Personal experiences of living donors (LDs) or recipients (Rs) can motivate more individuals to pursue living donor kidney transplant. After building a library of…
2021 American Transplant Congress
Predictors of Postoperative Atrial Fibrillation in an Urban, Obese Adult Renal Transplant Population
A. Lichvar, Z. Ress, M. Tabriz, H. Jenkins, T. Walsh, I. Tzvetanov, E. Benedetti, M. Campara
University of Illinois at Chicago, Chicago, IL
*Purpose: Postoperative atrial fibrillation (POAF) is a common surgical complication. Renal transplant (RT) recipients possess risk factors that may lead to a higher incidence of…
2021 American Transplant Congress
Belatacept Conversion in Elderly Renal Transplant Recipients
M. Durst¹, D. Felix¹, M. Jorgenson¹, J. Descourouez¹, B. C. Astor², D. Mandelbrot²
¹UW Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Describe the impact of conversion from a calcineurin inhibitor (CNI) based immunosuppressive regimen to belatacept in elderly renal transplant recipients.*Methods: Adult renal transplant patients…
2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
M. G. Naik, K. Sakurayama, K. Budde, F. Halleck
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…
2021 American Transplant Congress
Detrusor Reinforced Lich-Gregoir Ureteroneocystostomy for Kidney Transplants Recipients: Comparative Analysis of the First 100 Cases
R. H. Astolfi, J. Medina-Pestana, H. Tedesco Silva Junior, W. Aguiar
Urology, Universidade Federal de São Paulo, São Paulo, Brazil
*Purpose: In this study, we describe and compare the postoperative outcomes of our modified Lich-Gregoir ureteroneocystostomy (mLG), without DJ stent and with early bladder catheter…
2021 American Transplant Congress
Understanding Delays to Pediatric Kidney Transplant Wait-List Activation: Providers and Families Weigh in
C. M. Farkas-Skiles¹, A. Feinsinger², R. Pines³, A. D. Waterman⁴
¹Pediatric Nephrology, UCLA Mattel Children Hospital, Los Angeles, CA, ²Medicine and Philosophy, UCLA, Los Angeles, CA, ³Santa Barbara Cottage Hospital, Santa Barbara, CA, ⁴Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Since timely access to kidney transplant mediates mortality of children with kidney disease, we examined which factors most commonly affect providers’ decision-making to delay…
2021 American Transplant Congress
Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection After Change in Maintenance Immunosuppression Regimens in the First Year Post Kidney Transplant
M. Walsh, V. Peev, L. Lineberger, M. Brokhof, N. Kenyon, N. Alvey
Rush University Medical Center, Chicago, IL
*Purpose: The purpose of this study was to investigate whether the use of donor-derived cell-free DNA (dd-cfDNA) is an effective screening tool for allograft rejection…
2021 American Transplant Congress
PLA2R Status and Antibody Mediated Rejection in Kidney Transplant with Membranous Nephropathy
H. S. Han¹, A. Urisman², J. Shoji¹
¹Kidney Transplant Service, University of California, San Francisco, San Francisco, CA, ²Pathology, University of California, San Francisco, San Francisco, CA
*Purpose: Membranous nephropathy (MN) in transplanted kidney is categorized as de novo or recurrent disease. This immune complex glomerulopathy presents with varying levels of proteinuria,…